Trusted Resources: People & Places
Online groups, photo galleries and blogs
Team Sanfilippo Foundation is a nonprofit medical research foundation founded in 2008 by parents of children with Sanfilippo Syndrome. Our mission is to fund potential therapies that can be in clinical trials in the near future. We support Biotech, pharmecutical and research centers with potential therapies that are underfunded and provide assistance with connecting families to companies that need information for ongoing clinical work.
Team Sanfilippo is dedicated to provide assistance to families to gain access to clinical trials, treatments and compassionate use. We help coordinate necessary genetic testing required for families to participate in clinical trials or treatments. We are dedicated towards getting children of all ages access to clinical trials and treatments and assistance to families enrolled in clinical trials.
This foundation has been formed to receive and distribute funds for scientific and educational purposes within the meaning of 501(c)(3) of the Internal Revenue Code. Team Sanfilippo has developed a strategic plan to achieve our mission. Due to recent scientific advancements in the areas of enzyme replacement, gene therapy, and small molecules which has led to the initiation of clinical programs for Sanfilippo and other lysosomal storage diseases we will be focusing on the development of combined therapies to give children the best possible treatment strategies.
Related Content
-
Global Epidemiology of Mucopolysaccharidosis Type III (Sanfilippo Syndrome): An Updated Systematic Review and Meta-A...Mucopolysaccharidosis III, an autosomal ...
-
Kathleen BuckleyKathleen Buckley is the President of the...
-
The Rousse Family – Story of AustinWe are Angela and Louis Rousse, and we l...
-
RARE Scholars: Empowering Students Living With Rare DiseaseApplications open each year on Rare Dise...
-
Long-Term Safety and Clinical Outcomes of Intrathecal Heparan-N-Sulfatase in Patients With Sanfilippo Syndrome Type ...Currently, there is no effective therapy...
-
An Observational, Prospective, Multicenter, Natural History Study of Patients With Mucopolysaccharidosis Type IIIAMucopolysaccharidosis type IIIA (MPS III...
-
Terri L. Klein Received the WORLDSymposium 2021 Patient Advocate Leader (PAL) AwardTerri is a founding member of the Mucoli...